Plasma l-carnitine and risks of cardiovascular events and recurrent stroke after ischemic stroke: A nested case-control study.
- 2022-11
- RCT · n = 323
- Nutrition, metabolism, and cardiovascular diseases : NMCD 32(11)
- Jigang Du
- Mengyuan Miao
- Zian Lu
- Haichang Chen
- Anran Bao
- Bizhong Che
- Jintao Zhang
- Zhong Ju
- Tan Xu
- Jiang He
- Yonghong Zhang
- Chongke Zhong
- PubMed: 36155150
- DOI: 10.1016/j.numecd.2022.08.016
- High evidence
- Large Human Trial
- Clinical
Plasma l-carnitine was inversely associated with cardiovascular events (OR = 0.69, 95% CI: 0.57-0.84 per SD) ... Compared with the lowest tertile, adjusted ORs of cardiovascular events for participants in the highest tertiles were 0.35 (95% CI: 0.21-0.57)
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes